Course in the Wards Discharge Plans Management Course in the Wards Discharge Plans
Management: Course in the Wards Hospital Day 1: Admission Day Was hooked to D5NSS to run for 20gtts/min Requested to be started on: Ceftriaxone 2g/IV OD Azithromycin 500mg/tab 1tab OD for 3days Erdosteine 300mg/cap 1cap BID Paracetamol 500mg/tab 1tab q4 prn for T> 38C Amlodipine 5mg/tab 1tab OD Note: Medications were not started due to financial constraints
Management: Course in the Wards Hospital Day 1: Admission Day Laboratory Tests CBC w/ Platelet – anemia with leukocytosis Serum Na, K showed hyponatremia and hyperkalemia Creatinine, SGPT and SGOT were elevated iCA, iPO4, BUN, UTZ of KUBP, U/A, ABG were requested but were not done due to financial constraints Transfused with 1u pRBC Furosemide 40mg/IV 1dose and Salbutamol neblization q4 were requested
Management: Course in the Wards Hospital Day 1: Admission Day Patient was referred to Nephrology for co-management and BUA was requested, but was not done 12L ECG showed sinus rhythm, left ventricular hypertrophy by Sokolow-Lyon, peak T waves Chest X-ray was done Sputum GS and AFB for 3days were requested but were not done due to financial constraints
Management: Course in the Wards Hospital Day 2 Patient was hypertensive at 180/100mmHg was given Amlodipine 10mg/tab Ceftriaxone was started
Management: Course in the Wards Hospital Day 3 Salbutamol was shifted to Combivent nebulization q12, with gentle chest physiotherapy after each nebulization Repeat CBC with platelet, BUN, creatinine, Na, K were requested Patient had a BP of 140/90mmHg Was started on Metoprolol 50mg/tab 1tab BID
Management: Course in the Wards Hospital Day 4 Ceftriaxone was shifted to Cefuroxime 500mg/tab 1tab BID to complete 7days Was not done due to financial constraints
Management: Course in the Wards Hospital Day 5 Azithromycin, FeSO4 + FA, Metoprolol, as previously ordered, were started
Management: Course in the Wards Hospital Day 6 Cefuroxime, as previously ordered, was started Repeat CBC with platelet was done showed anemia, leukocytosis, thrombocytosis Repeat creatinine was done Declined but still elevated
Management: Course in the Wards Hospital Day 7 Patient’s condition improved and was stable discharge
Management: Discharge Plans Pharmacologic Non-Pharmacologic Procedures Check-Up
Discharge Plans: Pharmacologic Azithromycin MOA: blocks transpeptidation by binding to 50s ribosomal subunit of susceptible organisms and disrupting RNA-dependent protein synthesis at the chain elongation step. AE: Mild to moderate nausea, vomiting, abdominal pain, dyspepsia, flatulence, diarrhoea, cramping; angioedema, cholestatic jaundice; dizziness, headache, vertigo, somnolence; transient elevations of liver enzyme values. Dosage: 500mg/tab, 1 tablet OD for 3 days SRP: Php 150.00
Discharge Plans: Pharmacologic Cefuroxime MOA: binds to one or more of the penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. AE: Large doses can cause cerebral irritation and convulsions; nausea, vomiting, diarrhoea, GI disturbances; erythema multiforme, Stevens-Johnson syndrome, epidermal necrolysis, anaphylaxis, nephrotoxicity, pseudomembranous colitis. Dosage: 500mg/tab, 1 tablet BID for 7 days SRP: Php 75.00
Discharge Plans: Pharmacologic Amlodipine MOA: relaxes peripheral and coronary vascular smooth muscle. It produces coronary vasodilation by inhibiting the entry of Ca ions into the voltage-sensitive channels of the vascular smooth muscle and myocardium during depolarisation. It also increases myocardial O2 delivery in patients with vasospastic angina. AE: Headache, peripheral oedema, fatigue, somnolence, nausea, abdominal pain, flushing, dyspepsia, palpitations, dizziness. Rarely pruritus, rash, dyspnoea, asthenia, muscle cramps. Potentially Fatal: Hypotension, bradycardia, conductive system delay and CCF. Dosage: 10mg/tab, 1 tablet BID SRP: Php 22.00
Discharge Plans: Pharmacologic Metoprolol MOA:Metoprolol selectively inhibits β-adrenergic receptors but has little or no effect on β2-receptors except in high doses. It has no membrane-stabilising nor intrinsic sympathomimetic activity. AE:Bradycardia, hypotension, arterial insufficiency, chest pain, CHF, oedema, palpitation, syncope, gangrene; dizziness, fatigue, depression, confusion, headache, insomnia, short-term memory loss, nightmares, somnolence; pruritus, rash, increased psoriasis, reversible alopecia, Heart failure, heart block, bronchospasm. Dosage: 50mg/tab, 1 tablet BID SRP: Php 4.00
Discharge Plans: Pharmacologic Erdosteine MOA:contains two sulfhydryl groups, which are freed after metabolic transformation in the liver. The liberated sulfhydryl groups break the disulphide bonds, which hold the glycoprotein fibres of mucus together. This makes the bronchial secretions more fluid and enhances elimination. AE:Epigastralgia, nausea, vomiting, loose stools, spasmodic colitis, headache. Dosage: 300mg/cap, 1 capsule BID SRP: Php 19.00
Discharge Plans: Pharmacologic Ferrous Sulfate + FA MOA:Ferrous sulfate facilitates O2 transport via haemoglobin. It is used as iron source as it replaces iron found in haemoglobin, myoglobin and other enzymes. AE: GI irritation, abdominal pain and cramps, nausea, vomiting, constipation, diarrhoea, dark stool and discoloration of urine; heartburn. Dosage: 500mg/tablet, 1tablet BID SRP: Php 20.00
Discharge Plans: Non-Pharmacologic Getting plenty of rest and drinking of lots of fluids Active lifestyle (e.g . Daily exercise) Preventive measures Flu shot —for people at high risk, particularly the elderly, because pneumonia may be a complication of the flu Pneumococcal vaccine —recommended for: People over aged 65, or those who have a chronic illness, such as diabetes or sickle-cell disease Children under two years old
Discharge Plans: Non-Pharmacologic Lifestyle interventions: Weight loss (BMI<25 kg/m2) Reduction of dietary salt intake (<6g NaCl/day) Moderate alcohol consumption Men: </= 2 drinks per day Women: </= 1 drink per day Adapt DASH dietary plan Diet high in fruits and low-fat dairy products, reduced saturated and total fat Physical activity Regular aerobic activity (e.g. brisk walking for 30 mins/day)
Discharge Plans: Procedures CBC with platelet, serum Na, K, creatinine prior Ultrasound of KUBP
Discharge Plans: Check-up Return to UST Hospital for Check-up after 1 week or immediately when condition worsens.